Sessions by Topic Area

1380x420_19_AM_w_header2.jpg

Sessions by Topic Area

Below you will find the Annual Meeting program by topic area.  See the Program Brochure for full details.

Academic Medical Centers/Teaching Hospitals

I. Cannabis: The Past, the Present, the Future regarding Medical and Recreational Cannabis and the Myriad of Issues that Attorneys Should be Aware of from a Legal and Practical Perspective
L. 
Nonprofit Health Systems Investing in Innovation
Q. When Frankenstein Is Your PI: Regulatory and Practical Issues in Research Misconduct
BB. To Thine Own Self (Interest) Be True? Current Approaches to Managing Conflicts of Interest
UU. Promoting a Paradigm Shift in Primary Care: Innovative Collaborations between Hospitals and Health Centers

Antitrust

U. Will Your Deal be Caught in the Maw of Antitrust Review? (Advanced)
AA. Antitrust Hot Topics in Government Enforcement: Health Care Transactions, Conduct Matters, and Policy
PP. Pharmaceutical Pricing–How Much Is Too Much? Policy and Enforcement Perspectives
QQ. Provider Contracts and Agreements that Burn: Antitrust Consequences of Formal Written Contracts, Gentlemen’s Agreements, and Otherwise

Behavioral Health

S. Turning Around the Aircraft Carrier: How the Opioid Crisis and Outdated Regulations Create Legal Risk for Addiction Medicine Providers
OO. Mental Health Challenges across the Care Continuum

Business Law and Governance

E. Private Equity-Like Transactions between Hospitals and Physician Groups (With No PE Firms Involved)
U. Will Your Deal be Caught in the Maw of Antitrust Review? (Advanced)
Z. The Health Care Industry Is Transforming, One Deal at a Time, What you Need to Know to Prepare and Respond
AA. Antitrust Hot Topics in Government Enforcement: Health Care Transactions, Conduct Matters, and Policy
LL. What’s in a Name–The Ins and Outs of Health Care Brand Value
QQ. Provider Contracts and Agreements that Burn: Antitrust Consequences of Formal Written Contracts, Gentlemen’s Agreements, and Otherwise
UU. Promoting a Paradigm Shift in Primary Care: Innovative Collaborations between Hospitals and Health Centers

Compliance

O. Compliance Advice for the Post-Acute Provider: Assess, Audit and Do It Again!
BB. To Thine Own Self (Interest) Be True? Current Approaches to Managing Conflicts of Interest
CC. Ready or Not, Here It Comes: Managed Care Enforcement Trends and Key Risk Areas
EE. Hot Topics in Fraud and Abuse
KK. Keep Your Care Healthy: How to Prevent Your Digital Innovations from Calling in Sick
MM. 340B Basics and Oversight Updates

Dispute Resolution

P. Health Care Arbitration and Mediation: Teaming for Efficiency
NN. Medical Staff Fair Hearing Strategies and the Roles of In-House Counsel, Outside Counsel and the Hearing Officer

Diversity

TT. Inclusion of People with Disabilities in the Delivery of Legal Services
VV. A Seat at the Table: Perspectives on “Unexpected” Leadership in a Diverse and Evolving World

Fraud and Abuse

C. Best Practices in Criminal Health Care Investigations: An Insider Perspective
K. The Stark Reality: The Past, Present and Future of the Stark Law (Advanced)
T. Case Studies on the Beneficiary Inducement Prohibition
Y. OIG, CMS and OIG and Coordinated, Value-Based Care Delivery and Payment
CC. Ready or Not, Here It Comes: Managed Care Enforcement Trends and Key Risk Areas
EE. Hot Topics in Fraud and Abuse
GG. Are We There Yet? The Long Road to Modernizing the Fraud and Abuse Laws
SS. Health Law in the Trump Administration: Regulatory Reform and Future Priorities

Health Care Liability and Litigation

P. Health Care Arbitration and Mediation: Teaming for Efficiency
X. Immigrant Health Care: What's Changed? What Might Change? How Can We Prepare?
JJ. After Weinstein, USC/Tyndall, and the Catholic Church: Leadership Responses to Sex Abuse Allegations in the Era of #MeToo

Health Information and Technology

D. Practical Considerations of Use of AI in Litigation (Advanced)
V. Information Blocking Enforcement: What to Expect and How to Prepare
DD. Practical Advice for Implementing a Telehealth Initiative in an Integrated Health Care Delivery Setting
KK. Keep Your Care Healthy: How to Prevent Your Digital Innovations from Calling in Sick
RR. Evolving Theories in HIPAA Enforcement (Advanced)
WW. The Effect of HIPAA Protections on Emerging Health Information Technologies

Health Policy

Y. OIG, CMS and Coordinated, Value-based Care Delivery and Payment
GG. Are We There Yet? The Long Road to Modernizing the Fraud and Abuse Laws
SS. Health Law in the Trump Administration: Regulatory Reform and Future Priorities

Hospitals and Health Systems

E. Private Equity-Like Transactions between Hospitals and Physician Groups (With No PE Firms Involved)
F. Payer-Provider Reimbursement Conflicts in the Opioid Crisis: Resolving Tensions around Substance Abuse and New and Emerging Treatments
M. Strategic Planning for Physician Practice Acquisitions in the Post- Site-Neutrality Payment Era (Advanced)
R. Walking through the Minefield: Preparing for the Challenges in Implementation of a New Physician Compensation Model
X. Immigrant Health Care: What's Changed? What Might Change? How Can We Prepare?
Z. The Health Care Industry Is Transforming, One Deal at a Time, What You Need to Know to Prepare and Respond
UU. Promoting a Paradigm Shift in Primary Care: Innovative Collaborations between Hospitals and Health Centers

Labor and Employment

H. Wicked Tough Employment Law Issues
JJ. After Weinstein, USC/Tyndall, and the Catholic Church: Leadership Responses to Sex Abuse Allegations in the Era of #MeToo

Legal Ethics

J. Legal Ethics and the Use of Email and Social Media
HH. “I Probably Should Have Called You First”: Legal Ethics when the Facts are Bad or the Law Is Uncertain

Life Sciences

D. Practical Considerations of Use of AI in Litigation (Advanced)
II. Patient Assistance under Scrutiny
MM. 340B Basics and Oversight Updates
PP. Pharmaceutical Pricing–How Much Is Too Much? Policy and Enforcement Perspectives

Long Term Care

A. The New Patient Driven Payment Model (PDPM) is Nothing to SNF At
O. Compliance Advice for the Post-Acute Provider: Assess, Audit and Do It Again!

Medical Staff, Credentialing, and Peer Review

NN. Medical Staff Fair Hearing Strategies and the Roles of In-House Counsel, Outside Counsel, and Hearing Officer

Payers, Plans, and Managed Care

F. Payer-Provider Reimbursement Conflicts in the Opioid Crisis: Resolving Tensions around Substance Abuse and New and Emerging Treatments
N. Emerging Issues in Medicare Advantage and Medicare Drug Coverage
S. Turning around the Aircraft Carrier: How the Opioid Crisis and Outdated Regulations Create Legal Risk for Addiction Medicine Providers
X. Immigrant Health Care: What's Changed? What Might Change? How Can We Prepare?
CC. Ready or Not, Here It Comes: Managed Care Enforcement Trends and Key Risk Areas

Physicians and Physician Organizations

B. Physicians End Running the Plans (Advanced)
E. Private Equity-Like Transactions between Hospitals and Physician Groups (With No PE Firms Involved)
I. Cannabis: The Past, the Present, the Future regarding Medical and Recreational Cannabis and the Myriad of Issues that Attorneys Should be Aware of from a Legal and Practical Perspective
R. Walking through the Minefield: Preparing for the Challenges in Implementation of a New Physician Compensation Model

Professional Development

TT. Inclusion of People with Disabilities in the Delivery of Legal Services
XX.
Are We All in Sales? No Suh...Yah Huh: Business Development for Health Care Professionals-The Path to Trusted Advisor

Public Interest

S. Turning Around the Aircraft Carrier: How the Opioid Crisis and Outdated Regulations Create Legal Risk for Addiction Medicine Providers
OO.
Mental Health Challenges across the Care Continuum

Regulation, Accreditation, and Payment

F. Payer-Provider Reimbursement Conflicts in the Opioid Crisis: Resolving Tensions around Substance Abuse and New and Emerging Treatments
G.
The Medicare Shared Savings Program (MSSP) in 2019: New Legal Issues Presented by New Risk
M. Strategic Planning for Physician Practice Acquisitions in the Post- Site-Neutrality Payment Era (Advanced)
N. Emerging Issues in Medicare Advantage and Medicare Drug Coverage
T. Case Studies on the Beneficiary Inducement Prohibition
FF. Summary of Medicaid's Section 1115 Waivers: The Direction from Stewart v. Azar to the Future
MM. 340B Basics and Oversight Updates
PP. Pharmaceutical Pricing–How Much Is Too Much? Policy and Enforcement Perspectives

Tax and Finance

W. The Only Tax Panel You’ll Need for 2019: An Update on Tax Law Changes
LL. What’s in a Name–The Ins and Outs of Health Care Brand Value